Apple’s fall macOS release will let you build Shortcuts by typing what you want to happen. But Claude Code and Codex users ...

Just like NotebookLM itself, Google brought support for Notebooks of source files to Gemini earlier this year. Now Google’s ...

Spread the love“`html Google Drive has become a vital tool for individuals and businesses alike, providing a seamless way to store and share files online. If you’re looking to upload files to Google ...

I’ve been covering Android since 2023, when I joined Android Police, mostly focusing on AI and everything around Pixel and Galaxy phones. I’ve got a bachelor’s in IT with a major in AI, so I naturally ...

GitHub disabled 73 repositories across four Microsoft organizations on June 5 after the self-replicating supply-chain campaign known as ...

Fake Claude Code install sites are pushing malware that steals API keys, developer credentials, crypto wallets, and other sensitive data.

Security teams are staring at two AI problems at once. Adversaries are using AI to iterate on phishing kits, generate lures, and rotate infrastructure faster than blocklists can follow. Employees are ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

There is a quiet pattern emerging across engineering teams worldwide. Developers who try AI coding tools once almost never stop. This is not a hype cycle story. Hype cycles produce peaks and troughs.

HILLSBORO, Texas (KWTX) – A proposed 1,200‑plus megawatt data center in rural Hill County is now at the center of a federal lawsuit, as both the county and the City of Hillsboro debate how tightly to ...

Visa has announced an undisclosed investment in AI coding platform Replit. The two companies are also exploring how to integrate Visa’s payment products into Replit, so that developers — and the AI ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.